A lower dose (200 μg per injection for each mouse) of anti-PD-1 treatment also suppressed the growth of CT26.CL25 tumours in Balb/c mice on the control diet but not on MR diet (Extended Data Fig. 3h). Here, PDCD1 is linked to neoplasm.